Charles Conway - Dec 7, 2017 Form 4/A - Amendment Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Chief Scientific Officer
Signature
/s/ Jim Engelhart, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Dec 7, 2017
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/26/2021, 03:21 PM
Date Of Original Report
Dec 11, 2017
Next filing
Nov 26, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Employee Stock Option (Right to Buy) Award $0 +42.6K $0.00 42.6K Dec 7, 2017 Common Shares 42.6K $20.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 11, 2017, the reporting person filed a Form 4 which inadvertently reported that the reporting person was granted 32,612 Employee Stock Options on December 7, 2017. However, as reported in this amendment, the reporting person was actually granted 42,612 Employee Stock Options on such date.
F2 The shares underlying this option vest in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the reporting person's continuous service with the issuer at each vesting date.